Found: 6
Select item for more details and to access through your institution.
Regulation of Angiogenic Factors in Angiotensin II Infusion Model in Association With Tubulointerstitial Injuries
- Published in:
- American Journal of Hypertension, 2006, v. 19, n. 7, p. 718, doi. 10.1016/j.amjhyper.2005.09.022
- By:
- Publication type:
- Article
2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice.
- Published in:
- Diabetes, 2006, v. 55, n. 5, p. 1232, doi. 10.2337/db05-1367
- By:
- Publication type:
- Article
Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.
- Published in:
- 2004
- By:
- Publication type:
- journal article
A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy.
- Published in:
- Nephrology Dialysis Transplantation, 2008, v. 23, n. 2, p. 751
- By:
- Publication type:
- Article
Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
- Published in:
- Kidney International, 2005, v. 68, n. 2, p. 704, doi. 10.1111/j.1523-1755.2005.00449.x
- By:
- Publication type:
- Article